The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Last trade$12.27
Day change-$0.215 (-1.72%)
Day range$12.21 – $12.65
Volume1,147,643
Market cap$1.88B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.88B
Price / earnings
—
Price / book
12.12×
Price / sales
0.32×
EV / sales
0.86×
EV / EBITDA
13.19×
Profitability
Earnings per share
-$1.12
Return on assets
-2.3%
Return on equity
-108.39%
Dividend yield
2.87%
Liquidity and leverage
Debt / equity
24.73×
Current ratio
1.94×
Quick ratio
1.05×
Cash ratio
0.42×
Cash flow
Price / cash flow
4.7×
Price / free cash flow
8.9×
Free cash flow
$211M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.54B
$1.59B
$1.38B
$1.33B
$1.5B
$1.62B
$1.37B
$1.36B
Cost of revenue
$1.31B
$1.31B
$1.17B
$1.17B
$1.26B
$1.34B
$1.13B
$1.09B
Gross profit
$231M
$286M
$212M
$156M
$233M
$278M
$236M
$265M
Selling, general and administrative
-$25M
$469M
$147M
$130M
$122M
$424M
$123M
$170M
Research and development
$24M
$27M
$26M
$27M
$26M
$28M
$27M
$26M
Total operating expenses
$2M
$499M
$186M
$161M
$152M
$470M
$183M
$204M
Operating income
$229M
-$213M
$26M
-$5M
$81M
-$192M
$53M
$61M
Interest expense
-$69M
-$68M
-$69M
-$68M
-$68M
-$67M
-$66M
-$67M
Income before taxes
$222M
-$1M
-$22M
-$67M
$38M
-$248M
$0
$0
Income taxes
$26M
$273M
$7M
-$5M
-$8M
$131M
$5M
$12M
Net income
$196M
-$274M
-$29M
-$62M
$46M
-$379M
-$5M
-$12M
Net income attributable to common shareholders
$196M
-$274M
-$29M
-$61M
$46M
-$380M
-$5M
-$12M
EBITDA
$312M
-$130M
$118M
$80M
$164M
-$82M
$174M
$143M
Basic earnings per share
$1.29
-$1.81
-$0.19
-$0.41
$0.31
-$2.53
-$0.03
-$0.08
Diluted earnings per share
$1.29
-$1.81
-$0.19
-$0.41
$0.31
-$2.53
-$0.03
-$0.08
Recent news
Company coverage with links to the original publishers.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure, inadequate pricing, and insufficient reserves. Chemours and Fluence Energy also face similar securities fraud allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Fluence Energy is accused of making false statements about its ability to deliver backlog and meet fiscal 2026 guidance due to incomplete manufacturing facilities and unresolved production problems. Similar class actions have been filed against Everest Group and Chemours Company, with lead plaintiff deadlines in late 2026.
Three class action lawsuits have been filed against Chemours Company, Everest Group, Ltd., and Fluence Energy, Inc. for alleged securities fraud violations. Chemours is accused of overstating aftermarket demand for Opteon products and providing unreliable financial guidance. Investors in all three companies are encouraged to seek recovery, with lead plaintiff deadlines ranging from November 30, 2026 to December 28, 2026.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure and inadequate reserve pricing. Arbor Realty Trust and Chemours Company face similar allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
A class action lawsuit has been filed against Chemours Company (NYSE: CC) for alleged securities fraud. The complaint alleges that Chemours materially overstated aftermarket demand for Opteon products, failed to disclose decreasing demand, and provided unreliable financial guidance for 2026. Investors who purchased CC securities between February 20, 2026 and August 4, 2026 may be eligible to recover losses, with a lead plaintiff deadline of December 7, 2026.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Nov 16, 2026
$0.0875
Dec 15, 2026
recurring
Aug 14, 2026
$0.0875
Sep 15, 2026
recurring
May 15, 2026
$0.0875
Jun 16, 2026
recurring
Feb 27, 2026
$0.0875
Mar 13, 2026
recurring
Nov 14, 2025
$0.0875
Dec 15, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.